Capital Digestive Care – Page 2

Episode #51: Treating Celiac Disease by Restoring a Healthy Gut Wall (clinical trial on an innovative treatment shows promise)

Podcast: Play in new window | Download | Embed

Dr. Michael Weinstein interviews Dr. Andreas Muehler, chief medical officer of Immunic Therapeutics, which is developing a clinical pipeline of orally administered, small molecule therapies for chronic inflammatory and autoimmune diseases.

Episode #50: Predicting Cancer in Patients with Barrett’s Esophagus (a new test can help GI docs identify who is at greater risk)

Podcast: Play in new window | Download | Embed

Patients with Barrett’s Esophagus are at a higher risk to develop esophageal cancer, but it has always been challenging for physicians to determine which of their patients are at greatest risk.

Episode #48: New Biosimilars Available to Treat IBD (what it means for your patients)

Podcast: Play in new window | Download | Embed

This summer, four new biosimilar drugs became available to U.S. patients and several more are expected to hit the market soon.

Dr. Michael Weinstein interviews Laura D. Wingate, executive vice president, education, support, & advocacy for the Crohn’s & Colitis Foundation about the positive and negative implications of this development for patients.

Dr. David Heydt named Medical Director for Capital Digestive Care Laboratory

Capital Digestive Care has announced that David Heydt has been named medical director of Capital Digestive Care Laboratory.

Dr. Heydt will provide clinical oversight of the laboratory in Silver Spring, Maryland, as well as clinician and staff education while assisting with innovative laboratory projects and partnerships.